Moderna's NASDAQ 100 debut triggered a surge in buying, but the real question is whether the rally holds once index funds ...

<?xml encoding="utf-8" ?> A nationwide initiative to accelerate personalized cancer vaccine development is drawing fresh ...

Moderna stock has surged nearly 600% this year on a cancer vaccine trial result that almost no one outside the trial has ...

Covid-19 vaccination will be added to Singapore’s national childhood and adult immunisation schedules from Oct 12, with ...

Moderna stock popped 9% on Friday after the New York Times reported new details about an effort to speed up cancer vaccine development. Investors saw the mRNA biotech company, in particular, as a ...

According to the Wellcome Global Monitor, which surveyed more than 140,000 adults worldwide, 72% of people expressed at least some trust in science in 2025, down from 80% in 2020.

Summary COVID-19 vaccination will join Singapore’s national immunisation schedules from Oct 12 for older and medically ...

Moderna shares on Friday were driven by multiple catalysts, including a Nasdaq-100 entry, a New York Times report on a ...

Uthmeier filed a lawsuit against Pfizer Inc., alleging unfair and deceptive marketing of Pfizer’s COVID-19 vaccine.

BioNTech has seen its share price slide over recent years while the business reshapes itself beyond the COVID-19 vaccine boom ...

BioNTech pivots from Covid windfall to oncology with 33 trials and $19B cash; key pumitamig data post-2028. Click for more on ...

COVID-19 vaccination will join the national immunisation schedules, with updated vaccines available at over 600 GP clinics and other sites.